Mirtazapine-containing transdermally-absorbable skin-adhesive preparation
AssigneeYutoku Pharmaceutical Industries Co., Ltd.
InventorsMakoto Yoshitake, Kenta Nishimura
Life of this patent
Estimating the term…
Abstract
The purpose is to provide a mirtazapine-containing transdermal patch capable of suppressing deposition of a crystalline component derived from mirtazapine, deterioration in sense of use, and deterioration in adhesiveness to the skin. The transdermal patch contains a support, a drug-containing layer and a release liner, and the drug-containing layer contains mirtazapine and an organic acid.
Claims17
A transdermal patch comprising a support, a drug-containing layer, and a release liner, wherein the drug-containing layer comprises mirtazapine and an organic acid.
A method for producing a transdermal patch comprising a support, a drug-containing layer, and a release liner, the method comprising adding mirtazapine and an organic acid into the drug-containing layer.
A method for suppressing deposition of crystals of mirtazapine, the method comprising, in a transdermal patch comprising a support, a drug-containing layer, and a release liner, adding mirtazapine and an organic acid into the drug-containing layer.
Dependencies are inferred from the claim text.